Novo Nordisk A/S ADR buy Quitte
Start price
15.08.16
/
50%
€42.14
Target price
15.02.17
€44.65
Performance (%)
-26.05%
End price
15.02.17
€31.16
Summary
This prediction ended on 15.02.17 with a price of €31.16. The prediction for Novo Nordisk A/S ADR disappointed with a performance of -26.05%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | -1.167% | -1.167% | -33.681% | -60.923% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% | 63.672% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% | 109.562% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% | 54.912% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% | 69.801% |
Comments by Quitte for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
übertrieben
sooo schrecklich waren die Zahlen nicht
Analysten bleiben positiv
(Laufzeit überschritten)

